President Trump authorized emergency use of convalescent plasma to treat COVID-19 on Sunday. The treatment, which has been used on more than 64,000 patients already, infuses blood plasma from COVID-19 patients who have recovered and have antibodies with those who have been diagnosed. But evidence on whether it works has been inconclusive. ProPublica reporter Caroline Chen joins Hari Sreenivasan for more.

Stream your PBS favorites with the PBS app: https://to.pbs.org/2Jb8twG
Find more from PBS NewsHour at https://www.pbs.org/newshour
Subscribe to our YouTube channel: https://bit.ly/2HfsCD6

Follow us:
Facebook: http://www.pbs.org/newshour
Twitter: http://www.twitter.com/newshour
Instagram: http://www.instagram.com/newshour


Subscribe:
PBS NewsHour podcasts: https://www.pbs.org/newshour/podcasts
Newsletters: https://www.pbs.org/newshour/subscribe